Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-30T14:51:44.131Z Has data issue: false hasContentIssue false

Uso combinado de marcadores serotoninérgicos de las plaquetas y escalas psicopatológicas como detección selectiva diagnóstica de un trastorno psicótico frente a uno depresivo

Published online by Cambridge University Press:  12 May 2020

Nicolás Ramírez
Affiliation:
Benito Menni, CASM, Hospital de Granollers, Instituto de Salud Mental, Avda. Francesc Ribas s/n, 08400 Granollers, Barcelona, España
Belén Arranz
Affiliation:
Benito Menni, CASM, Hospital de Granollers, Instituto de Salud Mental, Avda. Francesc Ribas s/n, 08400 Granollers, Barcelona, España
Carmen Martín
Affiliation:
Benito Menni, CASM, Hospital de Granollers, Instituto de Salud Mental, Avda. Francesc Ribas s/n, 08400 Granollers, Barcelona, España
Luis San
Affiliation:
Benito Menni, CASM, Hospital de Granollers, Instituto de Salud Mental, Avda. Francesc Ribas s/n, 08400 Granollers, Barcelona, España
Get access

Resumen

Se presenta un caso individual de una paciente que sufre un primer episodio psicótico y se realiza el diagnóstico diferencial entre trastorno afectivo y psicosis mediante el uso combinado de marcadores serotoninérgicos periféricos y escalas psicopatológicas clínicas durante un seguimiento de 6 meses. Los resultados indican la necesidad de realizar estudios adicionales que combinen marcadores biológicos y clínicos de los trastornos psiquiátricos.

Type
Comunicación Breve
Copyright
Copyright © European Psychiatric Association 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Arranz, B, Rosel, P, Sarro, S, Ramírez, N, Dueñas, R, Cano, R, et al.Altered platelet serotonin 5-HT2A receptor density and second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Res 2003;118(2):165–74.CrossRefGoogle ScholarPubMed
Copolov, D, Crook, J. Biological markers and schizophrenia. Aust New Zealand J Psychiatry 2000;34(Suppl):108–12.CrossRefGoogle Scholar
Rosel, P, Arranz, B, San, L, Urretavizcaya, M, Marcusson, J, Navarro, MA. 5-HT2A receptors and their second messenger IP3 are only correlated in human brain and not in platelets. Neurosci Res Commun 1999;25(3):129–38.3.0.CO;2-#>CrossRefGoogle Scholar
Rosel, P, Arranz, B, Vallejo, J, Alvarez, P, Menchon, JM, Falencia, T, et al.Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. J Affect Disord 1999;52:225–33.CrossRefGoogle Scholar
Vallejo, J, Rosel, P, Arranz, B, Urretavizcaya, M, Menchón, JM, Contreras, F, et al.Loss of circadian variation of platelet BHHmipramine binding in delusional compared with non-delusional endogenously depressed patients. J Affect Disord 2002;72(1):95102.CrossRefGoogle ScholarPubMed